Ferring Pharmaceuticals is a privately owned, specialty biopharmaceutical group committed to building families and helping people live better lives. We are leaders in reproductive medicine with a strong heritage in gastroenterology and urology, and are at the forefront of innovation in uro-oncology gene therapy. Ferring was founded in 1950 and employs more than 7,000 people worldwide. The company is headquartered in Saint-Prex, Switzerland, and has operating subsidiaries in more than 50 countries which market its medicines in over 100 countries.
A new report, Closing Women’s Health Gap: a $1 Trillion Opportunity to Improve Lives and Economies, highlights the potential benefits of narrowing the gap in women's health.
The World Economic Forum's flagship initiative, Women's Health, works with a diverse group of stakeholders to showcase the socio-economic benefits of investing in women’s health.
